Douglas Errington

543 total citations
5 papers, 406 citations indexed

About

Douglas Errington is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Ophthalmology. According to data from OpenAlex, Douglas Errington has authored 5 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Ophthalmology. Recurrent topics in Douglas Errington's work include Cancer Diagnosis and Treatment (2 papers), Ocular Oncology and Treatments (2 papers) and Breast Cancer Treatment Studies (1 paper). Douglas Errington is often cited by papers focused on Cancer Diagnosis and Treatment (2 papers), Ocular Oncology and Treatments (2 papers) and Breast Cancer Treatment Studies (1 paper). Douglas Errington collaborates with scholars based in United Kingdom. Douglas Errington's co-authors include Derek Lowe, David Sutton, James S. Brown, Richard Shaw, Patrick Magennis, S.N. Rogers, David Vaughan, Julia A. Woolgar, I G Rennie and Sachin M. Salvi and has published in prestigious journals such as Journal of Clinical Oncology, Oral Oncology and Eye.

In The Last Decade

Douglas Errington

5 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Douglas Errington United Kingdom	4	243	153	119	90	82	5	406
Milovan Dimitrijević Serbia	8	108 0.4×	116 0.8×	53 0.4×	69 0.8×	34 0.4×	37	281
Janjira Petsuksiri Thailand	10	123 0.5×	119 0.8×	153 1.3×	8 0.1×	80 1.0×	28	354
Toshimichi Yasui Japan	11	236 1.0×	153 1.0×	201 1.7×	11 0.1×	71 0.9×	21	412
P.J. Kreinbrink United States	6	256 1.1×	109 0.7×	128 1.1×	86 1.0×	65 0.8×	12	357
Célia M. Viégas Brazil	10	134 0.6×	71 0.5×	158 1.3×	21 0.2×	283 3.5×	19	477
M.M. Rietbergen Netherlands	5	303 1.2×	183 1.2×	94 0.8×	41 0.5×	53 0.6×	6	344
Keith Kwan Canada	9	133 0.5×	113 0.7×	89 0.7×	6 0.1×	131 1.6×	30	314
Amanda‐Louise Fenger Carlander Denmark	9	364 1.5×	190 1.2×	124 1.0×	45 0.5×	69 0.8×	27	459
Vidhya Karivedu United States	10	86 0.4×	71 0.5×	129 1.1×	8 0.1×	129 1.6×	35	322
Micah Ellison United Kingdom	2	220 0.9×	129 0.8×	112 0.9×	37 0.4×	52 0.6×	2	350

Countries citing papers authored by Douglas Errington

Since Specialization

Citations

This map shows the geographic impact of Douglas Errington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Errington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Errington more than expected).

Fields of papers citing papers by Douglas Errington

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Errington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Errington. The network helps show where Douglas Errington may publish in the future.

Co-authorship network of co-authors of Douglas Errington

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Errington. A scholar is included among the top collaborators of Douglas Errington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Errington. Douglas Errington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Khan, Anzalee, Helen Wong, Samantha J. Mills, et al.. (2023). A comparison of the efficacy of trastuzumab deruxtecan in advanced HER2-positive breast cancer: active brain metastasis versus progressive extracranial disease alone. ESMO Open. 8(6). 102033–102033. 5 indexed citations

2.

Hussain, Rumana, Bradley Pittam, Azzam Taktak, et al.. (2022). Proton beam radiotherapy for choroidal and ciliary body melanoma in the UK—national audit of referral patterns of 1084 cases. Eye. 37(5). 1033–1036. 6 indexed citations

3.

Hall, Benjamin, Helen Innes, Shaun Tolan, et al.. (2019). Real-world evidence regarding the efficacy and toxicity of neoadjuvant trastuzumab and pertuzumab in the management of HER2-positive early-breast cancer.. Journal of Clinical Oncology. 37(15_suppl). e12108–e12108. 3 indexed citations

4.

Salvi, Sachin M., et al.. (2015). Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma. Eye. 29(9). 1194–1198. 53 indexed citations

5.

Rogers, S.N., James S. Brown, Julia A. Woolgar, et al.. (2008). Survival following primary surgery for oral cancer. Oral Oncology. 45(3). 201–211. 339 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact